Amended Statement of Beneficial Ownership (sc 13d/a)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934

(Amendment No. 1)

Alcentra Capital Corporation

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

01374T102

(CUSIP Number)

The Bank of New York Mellon Corporation
One Wall Street
New York, New York 10286

(Name, Address and Telephone Number of Person Authorized

to Receive Notices and Communications)

April 15, 2015

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 01374T102

SCHEDULE 13D

Page 1 of 4

1	NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) THE BANK OF NEW YORK MELLON CORPORATION
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)	¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

3,291,045

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

3,298,300

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,298,300
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 24.4%
14	TYPE OF REPORTING PERSON CO; HC

CUSIP No. 01374T102

SCHEDULE 13D

Page 2 of 4

1	NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) BNY MELLON, NATIONAL ASSOCIATION
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)	¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

1,360,803

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

1,368,058

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,368,058
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 10.1%
14	TYPE OF REPORTING PERSON BK

CUSIP No. 01374T102

Page 3 of 4

1	NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) BNY ALCENTRA GROUP HOLDINGS, INC.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)	¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

1,930,242

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

1,930,242

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,930,242
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 14.3%
14	TYPE OF REPORTING PERSON CO; IA

CUSIP No. 01374T102

Page 4 of 4

1	NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) ALCENTRA INVESTMENTS LIMITED
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)	¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

1,475,620

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

1,475,620

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,475,620
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 10.9%
14	TYPE OF REPORTING PERSON CO; IA

INTRODUCTORY NOTE

This Amendment No. 1 to Schedule 13D (“Amendment No. 1”) is being filed to update information set forth in the initial Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) on March 12, 2015 (the “Schedule 13D”), filed to report the beneficial ownership of shares of common stock, par value $0.001 per share of Alcentra Capital Corporation, a Maryland corporation (the “Issuer”), by each of the reporting persons named in such Schedule 13D (each, individually, a “Reporting Person” and collectively the “Reporting Persons”). Except as herein amended or supplemented, all other information in the Schedule 13D is as set forth therein.

Explanatory Note: the date of the event which requires the filing of this Amendment No. 1 is April 15, 2015; however, information contained in this Amendment No. 1 reflects the Reporting Persons’ beneficial ownership as of April 28, 2015.

Item 2.

Identity and Background

Item 2 of the Schedule 13D is hereby amended to add the following:

Certain information with respect to the directors and executive officers of the Reporting Persons is set forth in Exhibit 99.5 attached hereto, including each director’s and each executive officer’s business address, present principal occupation or employment, citizenship and other information.

Item 3.

Source and Amount of Funds or Other Consideration

Item 3 of the Schedule 13D is hereby amended to add the following:

On April 6, 2015, Alcentra Investments Limited received 24,621 shares of the Issuer’s common stock, through participation in a dividend reinvestment plan (“DRIP”) of the Issuer, at a purchase price of approximately $13.976044 per share. Other than the reinvestment of such dividend, no consideration was paid by Alcentra Investments Limited to acquire such shares.

As of April 28, 2015, Alcentra NY, LLC had purchased 37,860 shares of the Issuer’s common stock on the open market for an aggregate purchase price of $524,635.41 and Alcentra Ltd. has purchased 141,505 shares of the Issuer’s common stock on the market for an aggregate purchase price of $1,960,869.87. Alcentra Ltd. is indirectly wholly owned by The Bank of New York Mellon Corporation.

Item 4.

Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended to add the following:

On March 23, 2015, in connection with a long-term incentive compensation plan maintained by Alcentra NY, LLC and Alcentra Ltd. for its employees, Alcentra NY, LLC and Alcentra Ltd. entered into a purchase plan to purchase the Issuer’s shares of common stock on the open market in compliance with the applicable requirements of Rule 10b5-1 and Rule 10b-18 under the Securities Exchange Act of 1934 (the “March 2015 Purchase Program”). In accordance with the March 2015 Purchase Program, as of April 28, 2015 Alcentra NY, LLC had acquired 37,860 shares of the Issuer’s common stock on the open market for an aggregate purchase price of $524,635.41 and Alcentra Ltd. had acquired 141,505 shares of the Issuer’s common stock on the open market for an aggregate purchase price of $1,960,869.87.

Alcentra Investments Limited is enrolled in the DRIP and currently elects to reinvest the dividends it receives in respect of a portion of the Issuer’s common stock owned by it in additional shares of the Issuer’s common stock.

Except with respect to additional purchases pursuant to the March 2015 Purchase Program and the DRIP, the Reporting Persons have no present plans or intentions which would result in or relate to any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

Item 5.

Interest in Securities of the Issuer

Items 5(a) and 5(b) of the Schedule 13D are hereby amended and restated in their entirety as follows:

The percentages set forth below and on pages 1 through 4 above were calculated based on 13,516,766 shares of the Issuer’s common stock outstanding as of March 17, 2015, as disclosed in the Issuer’s amended annual report on Form 10-K/A filed with the SEC on March 18, 2015.

(a)(i) The Bank of New York Mellon Corporation may be deemed to beneficially own 3,298,300, or 24.4%, of the Issuer’s outstanding shares of common stock; (ii) BNY Mellon, National Association may be deemed to beneficially own 1,368,058, or 10.1%, of the Issuer’s outstanding shares of common stock; (iii) BNY Alcentra Group Holdings, Inc. may be deemed to beneficially own 1,930,242, or 14.3%, of the Issuer’s outstanding shares of common stock; and (iv) Alcentra Investments Limited may be deemed to beneficially own 1,475,620, or 10.9%, of the Issuer’s outstanding shares of common stock.

(b)(i) The Bank of New York Mellon Corporation shares voting power with respect to 3,291,045 of the Issuer’s shares of common stock held by Alcentra NY, LLC, Alcentra Ltd., Alcentra Investments Limited, BNY Mellon Global Credit Alternatives Fund and BNY Mellon National Association and shares dispositive power with respect to 3,298,300 of the Issuer’s shares of common stock held by Alcentra NY, LLC, Alcentra Ltd., Alcentra Investments Limited, BNY Mellon Global Credit Alternatives Fund and BNY Mellon National Association.

(ii) BNY Mellon, National Association shares voting power with respect to 1,360,803 shares of the Issuer’s shares of common stock held by clients of its wealth management branch and dispositive power with respect to 1,368,058 shares of the Issuer’s shares of common stock held by clients of its wealth management branch.

(iii) BNY Alcentra Group Holdings, Inc. shares voting and dispositive power with respect to 1,930,242 of the Issuer’s shares of common stock held by Alcentra NY, LLC, Alcentra Ltd., Alcentra Investments Limited and BNY Mellon Global Credit Alternatives Fund.

(iv) Alcentra Investments Limited shares voting and dispositive power with respect to 1,475,620 of the Issuer’s shares of common stock.

Item 5(c) of the Schedule 13D is hereby amended to add the following:

(c) Since March 12, 2015, the date on which the Schedule 13D was filed with the SEC, Alcentra NY, LLC has purchased a total of 37,860 of the Issuer’s shares of common stock which are reported as beneficially owned by The Bank of New York Mellon Corporation and BNY Alcentra Group Holdings, Inc. and Alcentra Ltd. has purchased a total of 141,505 of the Issuer’s shares of common stock which are reported as beneficially owned by The Bank of New York Mellon Corporation and BNY Alcentra Group Holdings, Inc. Please see the chart below detailing the date, price and number of shares purchased in connection with each acquisition made since the Schedule 13D. Alcentra NY, LLC and Alcentra Ltd. made all such acquisitions in the open market.

	Settlement	Alcentra NY,				Total
Trade Date	Date	LLC		Alcentra Ltd.		Shares		Price		Amount
3/23/2015	3/26/2015		1,733		6,480		8,213		14.2470	$	117,010.61
3/24/2015	3/27/2015		1,733		6,480		8,213		14.0047	$	115,020.60
3/25/2015	3/30/2015		1,733		6,480		8,213		13.8800	$	113,996.44
3/26/2015	3/31/2015		1,733		6,480		8,213		13.8000	$	113,339.40
3/27/2015	4/1/2015		1,733		6,480		8,213		13.3000	$	109,232.90
3/30/2015	4/2/2015		740		2,765		3,505		13.4800	$	47,247.40
3/31/2015	4/3/2015		1,985		7,420		9,405		13.7430	$	129,252.92
4/1/2015	4/7/2015		845		3,156		4,001		13.3600	$	53,453.36
4/2/2015	4/8/2015		844		3,156		4,000		13.5500	$	54,200.00
4/6/2015	4/9/2015		2,182		8,156		10,338		13.5300	$	139,873.14
4/7/2015	4/10/2015		1,182		4,418		5,600		13.6594	$	76,492.64
4/8/2015	4/13/2015		2,182		8,156		10,338		14.0910	$	145,672.76
4/9/2015	4/14/2015		2,182		8,156		10,338		14.0875	$	145,636.58
4/10/2015	4/15/2015		1,615		6,035		7,650		14.1910	$	108,561.15
4/13/2015	4/16/2015		2,618		9,782		12,400		14.1261	$	175,163.64
4/14/2015	4/17/2015		950		3,550		4,500		13.9585	$	62,813.25
4/15/2015	4/18/2015		929		3,471		4,400		13.7563	$	60,527.72
4/16/2015	4/21/2015		780		2,914		3,694		13.7984	$	50,971.29
4/17/2015	4/22/2015		1,752		6,548		8,300		13.9345	$	115,656.35
4/20/2015	4/23/2015		1,056		3,944		5,000		13.9598	$	69,799.00
4/21/2015	4/24/2015		882		3,293		4,175		13.8503	$	57,825.00
4/22/2015	4/27/2015		1,675		6,259		7,934		13.7849	$	109,369.40
4/23/2015	4/28/2015		839		3,135		3,974		13.8183	$	54,913.92
4/24/2015	4/29/2015		1,456		5,443		6,899		13.8606	$	95,624.28
4/27/2015	4/30/2015		1,340		5,009		6,349		13.8173	$	87,726.04
4/28/2015	5/1/2015		1,161		4,339		5,500		13.8410	$	76,125.50
Total:			37,860		141,505		179,365		13.8572	$	2,485,505.28

On April 6, 2015, Alcentra Investments Limited received 24,621 shares of the Issuer’s common stock, through participation in the DRIP, at a purchase price of approximately $13.976044 per share.

In addition to the transactions listed above, since March 12, 2015, certain clients of the wealth management branch of BNY Mellon, National Association have engaged in transactions whereby the shares previously held in a wealth management account were transferred, sold, or otherwise disposed of by certain wealth management clients.

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respects to Securities of the Issuer

The information contained in Items 4 and 5 are incorporated herein by reference. Other than as described elsewhere in this Statement, the Reporting Persons have no understandings, arrangements, relationships or contracts relating to the Issuer’s shares of common stock which are required to be described hereunder.

Item 7.

Materials to be Filed as Exhibits

Exhibit
Number		Description of Exhibit

Exhibit 1		Form of Asset Purchase Agreement by and between the Issuer and BNY Mellon-Alcentra Mezzanine III, L.P. and Alcentra NY, LLC (incorporated by reference to Exhibit (k)(4) to pre-effective amendment no. 4 to the Issuer’s Registration Statement on Form N-2 (File No. 333-194521) filed on May 8, 2014).

Exhibit 99.1		Directors and Executive Officers of the Reporting Persons (incorporated by reference to Exhibit 99.1 to the Schedule 13D filed on March 12, 2015)

Exhibit 99.2		Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Schedule 13D filed on March 12, 2015)

Exhibit 99.3		Power of Attorney for the Bank of New York Mellon Corporation and BNY Mellon, National Association (incorporated by reference to Exhibit 99.1 to the Schedule 13D filed on March 12, 2015)

Exhibit 99.4		Designation of Power of Attorney for the Bank of New York Mellon Corporation

Exhibit 99.5		Directors and Executive Officers of the Reporting Persons

SIGNATURES

After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: April 30, 2015

	THE BANK OF NEW YORK MELLON CORPORATION

	By:	/s/ Ivan Arias
		Name: Ivan Arias
		Title: Attorney-In-Fact for
		The Bank of New York Mellon Corporation

	BNY MELLON, NATIONAL ASSOCIATION

	By:	/s/ Ivan Arias
		Name: Ivan Arias
		Title: Attorney-In-Fact for
		BNY Mellon, National Association

	BNY ALCENTRA GROUP HOLDINGS, INC.

	By:	/s/ David Forbes-Nixon
		Name: David Forbes-Nixon
		Title: President

	ALCENTRA INVESTMENTS LIMITED

	By:	/s/ David Forbes-Nixon
		Name: David Forbes-Nixon
		Title: Vice President

Exhibit 99.4

THE BANK OF NEW YORK MELLON CORPORATION

DESIGNATION OF POWER OF ATTORNEY

I, Nicholas R. Darrow, in my capacity as Attorney-in Fact for The Bank of New York Mellon Corporation (“BNY Mellon Corporation”) and those BNY Mellon Corporation subsidiaries listed on Exhibit A attached hereto (the “BNY Mellon Subsidiaries”, and together with BNY Mellon Corporation, the “BNY Mellon Companies”), pursuant to the authority granted to me by the BNY Mellon Companies through a Power of Attorney, hereby make, constitute each of Lori Cimino, Ivan Arias, and Andrew Weiser (the “Authorized Persons”, and each an “Authorized Person”), acting individually, the true and lawful attorney of each of the BNY Mellon Companies, to execute and deliver in their name and on their behalf, whether a BNY Mellon Company is acting individually or as representative of all BNY Mellon Companies, with respect to securities which may be deemed to be beneficially owned by a BNY Mellon Company or under a BNY Mellon Company’s investment discretion, any and all filings required to be made under:

the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including those filings required to be submitted on Form 13F, Schedule 13G and Form SH, and

the laws of any jurisdiction other than the United States of America, including those filings made to disclose securities holdings as required to be submitted to regulatory agencies, exchanges and/or issuers,

delegating unto said Authorized Person, power to act as attorney-in-fact power, and authority to correspond with issuers, regulatory authorities, and other entities as is required in support of the filings referenced above, and to act in the premises as fully and to all intents and purposes as the Company might or could do to comply with the applicable regulations if personally present by one of its authorized signatories (including, but not limited to, instructing local counsel on a Company's behalf), hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof.

This Power of Attorney granted under this Designation to the Authorized Person shall expire as to each particular person upon the earlier of: (i) the date on which BNY Mellon Corporation notifies such person in writing that he/she no longer has such power and authority and (ii) the date on which such person ceases to be an employee of BNY Mellon Corporation or a BNY Mellon Company.

/s/ NICHOLAS R. DARROW
Nicholas R. Darrow
Attorney-in-Fact

Dated: 20 April 2015

EXHIBIT A

LIST OF BNY MELLON SUBSIDIARIES

BANKS/BANK HOLDING COMPANIES

The Bank of New York Mellon

The Bank of New York Mellon Trust Company, National Association

BNY Mellon, National Association

BNY Mellon Trust of Delaware

INVESTMENT ADVISERS AND/OR BROKER-DEALERS

BNY Mellon ARX Investimentos Ltda (parent holding company of BNY Mellon Ativos Financeiros Ltda)

The Boston Company Asset Management LLC

The Dreyfus Corporation (parent holding company of MBSC Securities Corporation)

Insight Investment Management (Global) Limited

Lockwood Advisors, Inc.

Mellon Capital Management Corporation

Newton Capital Management Limited

Newton Investment Management Limited

Standish Mellon Asset Management Company LLC

CenterSquare Investment Management, Inc.

CenterSquare Investment Management Holdings, Inc.

Walter Scott & Partners Limited

BNY Mellon Wealth Management, Advisory Services, Inc.

BNY Mellon Trust Company(Cayman) Limited

BNY Mellon Managed Investments Limited.

BNY Mellon Investment Management Cayman Limited

Cutwater Asset Management Corporation

Cutwater Investor Services Corporation

BNY Mellon Capital Markets, LLC.

MBSC Securities Corporation

Pershing LLC

PARENT HOLDING COMPANIES/CONTROL PERSONS

The Bank of New York Mellon Corporation

B.N.Y. Holdings (Delaware) Corporation (parent holding company of BNY Mellon Trust of Delaware)

Insight Investment Management Limited (parent holding company of Insight Investment Management (Global) Limited)

MAM (MA) Holding Trust (parent holding company of Standish Mellon Asset Management Company LLC; The Boston Company Asset Management LLC)

MBC Investments Corporation (parent holding company of Mellon Capital Management Corporation; BNY Mellon Investment Management (Jersey) Ltd.)

BNY Mellon Investment Management (Jersey) Ltd. (parent holding company of BNY Mellon Investment Management (Europe) Ltd.)

BNY Mellon Investment Management (Europe) Ltd. (parent holding company of BNY Mellon Investment Management Europe Holdings Ltd.; BNY Mellon Investment Management Cayman Limited)

BNY Mellon Investment Management Europe Holdings Ltd. (parent holding company of BNY Mellon International Asset Management Group Limited; Mellon JV Limited)

BNY Mellon International Asset Management Group Limited (parent holding company of Newton Management Limited; BNY Mellon International Asset Management (Holdings) Limited; Insight Investment Management Limited)

BNY Mellon Asset Management International Holdings Limited (parent holding company of BNY Mellon Asset Management Japan Limited)

Mellon Overseas Investment Corporation (parent holding company to BNY Mellon Servicos Financeiros Distribuidora de Titulos e ValoresMobiliarios S.A. and (indirect) BNY Mellon Gestao de Patrimonio Ltda; Mellon Canada Holding Company)

Newton Management Limited (parent holding company of Newton Capital Management Limited; Newton Investment Management Limited)

Pershing Group LLC (parent holding company of Lockwood Advisors, Inc. and Pershing LLC)

The Bank of New York Mellon SA/NV (parent holding company of BNY Mellon Service Kapitalanlage-Gesellschaft mbH)

Mellon JV Limited (parent holding company of BNY Mellon Investment Holdings (Germany) Limited)

BNY Mellon Investment Holdings (Germany) Limited (parent holding company of Meriten Investment Management GmbH)

BNY Mellon International Asset Management (Holdings) Limited (parent holding company of BNY Mellon International Asset Management (Holdings) No. 1 Limited)

BNY Mellon International Asset Management (Holdings) No. 1 Limited (parent holding company of Walter Scott & Partners Limited)

Mellon Canada Holding Company (parent holding company of BNY Mellon Wealth Management, Advisory Services, Inc)

BNY International Financing Corporation (parent holding company ofBNY Mellon Trust Company (Cayman) Limited)

BNY Capital Markets Holdings, Inc. (parent holding company of BNY Mellon Capital Markets, LLC.)

Cutwater Holdings LLC (parent holding company of Cutwater Asset Management Corporation; Cutwater Investor Services Corporation)

FUND ADMINISTRATORS

BNY Mellon Service Kapitalanlage- Gesellschaft Mbh

Meriten Investment Management Gmbh

Exhibit 99.5

The Bank of New York Mellon Corporation

The name of each director and executive officer of The Bank of New York Mellon Corporation is set forth below. The business address of each person listed below is c/o The Bank of New York Mellon Corporation, One Wall Street, New York, New York 10286. Each person is a citizen of the United States of America.

Directors

Name		Occupation

Nicholas M. Donofrio Joseph J. Echevarria Edward P. Garden		Retired EVP, Innovation and Technology of IBM Corporation Retired CEO of Deloitte LLP Chief Investment Officer and a founding partner of Trian Fund Management, L.P.
Jeffrey A. Goldstein		Managing Director, Hellman & Friedman LLP
Gerald L. Hassell John M. Hinshaw		Chairman and CEO of The Bank of New York Mellon Corporation Executive Vice President of Technology and Operations at Hewlett-Packard Company
Edmund F. “Ted” Kelly		Retired Chairman of Liberty Mutual Group
Richard J. Kogan		Principal of The KOGAN Group LLC, RJKogan AP LLC and Jayleen Art Associates LLC
John A. Luke, Jr.		Chairman and CEO of MeadWestvaco Corporation
Mark A. Nordenberg		Chancellor, CEO and Distinguished Service Professor of Law at the University of Pittsburgh
Catherine A. Rein		Retired Senior EVP and Chief Administrative Officer of MetLife, Inc.
William C. Richardson		President and CEO Emeritus of The W.K. Kellogg Foundation and President Emeritus, the Johns Hopkins University
Samuel C. Scott III		Retired Chairman, President and CEO of Corn Products International, Inc.
Wesley W. von Schack		Chairman of AEGIS Insurance Services, Inc.

Executive Officers

Name		Position
Gerald L. Hassell		Chairman and Chief Executive Officer
Karen B. Peetz		President
Curtis Y. Arledge		Vice Chairman, CEO, Investment Management
Thomas P. Gibbons		Vice Chairman and Chief Financial Officer
Richard Brueckner		Chief of Staff
Brian T. Shea		Vice Chairman, Chief Executive Officer, Investment Services
J. Kevin McCarthy		General Counsel
Monique R. Herena		Senior Vice President and Chief Human Resources Officer
Kurtis R. Kurimsky		Acting Controller and Principal Accounting Officer
James S. Wiener		Senior Executive Vice President and Chief Risk Officer

BNY Mellon, National Association

The name of each director and executive officer of BNY Mellon, National Association is set forth below. The business address of each person listed below is c/o BNY Mellon, National Association, 1 BNY Mellon Center, Pittsburgh, PA 15258-0001. Each person is a citizen of the United States of America.

Directors

Name		Occupation
Nicholas M. Donofrio		Retired EVP, Innovation and Technology of IBM Corporation
Joseph J. Echevarria		Retired CEO of Deloitte LLP
Edward P. Garden		Chief Investment Officer and a founding partner of Trian Fund Management, L.P.
Jeffrey A. Goldstein		Managing Director, Hellman & Friedman LLP
Gerald L. Hassell John M. Hinshaw		Chairman and CEO of The Bank of New York Mellon Corporation Executive Vice President of Technology and Operations at Hewlett-Packard Company
Edmund F. “Ted” Kelly		Retired Chairman of Liberty Mutual Group
Richard J. Kogan		Principal of The KOGAN Group LLC, RJKogan AP LLC and Jayleen Art Associates LLC
John A. Luke, Jr.		Chairman and CEO of MeadWestvaco Corporation
Mark A. Nordenberg		Chancellor, CEO and Distinguished Service Professor of Law at the University of Pittsburgh
Catherine A. Rein		Retired Senior EVP and Chief Administrative Officer of MetLife, Inc.
William C. Richardson		President and CEO Emeritus of The W.K. Kellogg Foundation and President Emeritus, the Johns Hopkins University
Samuel C. Scott III		Retired Chairman, President and CEO of Corn Products International, Inc.
Wesley W. von Schack		Chairman of AEGIS Insurance Services, Inc.

Executive Officers

Name		Position
Gerald L. Hassell		Chairman and Chief Executive Officer
Karen B. Peetz		President
Curtis Y. Arledge		Vice Chairman
Thomas P. Gibbons		Vice Chairman and Chief Financial Officer
Richard Brueckner		Chief of Staff
Brian T. Shea		Vice Chairman
J. Kevin McCarthy		General Counsel
Monique R. Herena		Senior Vice President and Chief Human Resources Officer
Kurtis R. Kurimsky		Acting Controller and Principal Accounting Officer
James S. Wiener		Senior Executive Vice President and Chief Risk Officer

BNY Alcentra Group Holdings, Inc.

The name of each director and executive officer of BNY Alcentra Group Holdings, Inc. is set forth below. The business address of each person listed below is c/o BNY Alcentra Group Holdings, Inc., 10 Gresham Street, London, England, EC2V 7JD. Each person is a citizen of the United States of America with the exception of Robert Bennett, David Forbes-Nixon and Paul Hatfield who are citizens of the United Kingdom.

Directors

Name		Occupation

Robert Bennett		Alcentra Finance Director & Chief Operating Officer
David Forbes-Nixon		Alcentra Chairman & Chief Executive Officer
Mitchell E. Harris		President of BNY Mellon Investment Management
Edward H. Ladd		Chairman Emeritus, Standish Mellon Asset Management Company LLC
Steven Lipiner		Chief Financial Officer for BNY Mellon Investment Management

Executive Officers

Name		Position

David Forbes-Nixon		President
Robert Bennett		Vice President
Paul J. Echausse		Vice President
Scott Gold		Vice President
Paul Hatfield		Vice President
Reza Sarmasti		Vice President

Alcentra Investments Limited

The name of each director and executive officer of Alcentra Investments Limited is set forth below. The business address of each person listed below is c/o Alcentra Investments Limited, 10 Gresham Street, London, England, EC2V 7JD. Each person is a citizen of the United Kingdom, with the exception of Appleby Services (Bermuda) Ltd., which is a corporation organized under the laws of Bermuda, and Mitchel E. Harris who is a citizen of the United States of America.

Directors

Name		Occupation

Robert Bennett		Alcentra Finance Director & Chief Operating Officer
David Forbes-Nixon		Alcentra Chairman & Chief Executive Officer
Mitchell E. Harris		President of BNY Mellon Investment Management